ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Ralph Steinman Wins Nobel Prize Three Days After His Death

October 14, 2011

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

Kennedy Bills Would Raise Salaries, Restore Construction, Expand Biomedical Research Support

July 14, 1989

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014